Scancell Holdings plc (LON:SCLP – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 11.48 ($0.14) and traded as low as GBX 9.40 ($0.12). Scancell shares last traded at GBX 9.60 ($0.12), with a volume of 244,525 shares trading hands.
Scancell Stock Performance
The company has a debt-to-equity ratio of 61.41, a current ratio of 8.63 and a quick ratio of 13.01. The company has a market capitalization of £89.07 million, a price-to-earnings ratio of -960.00 and a beta of 0.34. The stock has a 50 day simple moving average of GBX 10.47 and a two-hundred day simple moving average of GBX 11.48.
About Scancell
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.
Further Reading
- Five stocks we like better than Scancell
- Where Do I Find 52-Week Highs and Lows?
- Comprehensive Analysis of PayPal Stock
- Golden Cross Stocks: Pattern, Examples and Charts
- Intuitive Surgical Stock Can Trend Much Higher This Year
- What Are Dividends? Buy the Best Dividend Stocks
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.
